A Phase 3 clinical study from Italfarmaco is now enrolling adults with polycythemia vera (PV) to evaluate an investigational treatment.
A study doctor can help determine eligibility. Participation is voluntary.
Learn more: https://f.mtr.cool/ivmlznwcpb
